BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15337638)

  • 1. Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro.
    Juergens UR; Stöber M; Libertus H; Darlath W; Gillissen A; Vetter H
    Eur J Med Res; 2004 Jul; 9(7):365-70. PubMed ID: 15337638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation using dynamic ECG of the effects of reproterol (a new beta-2 adrenergic receptor agonist) on the heart conduction system].
    Citone C; Carelli M; Di Marcotullio G; Tubaro M; Milazzotto F
    Clin Ter; 1984 Sep; 110(5):429-36. PubMed ID: 6149836
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of purinergic system in tracheobronchial reactivity of healthy and bronchopathic subjects.
    Susanna V; Loffreda A; Matera MG; Servodio R; Filippelli A; Santagata A; Montanaro C; Carapella N; Marmo E
    Int J Tissue React; 1990; 12(1):59-65. PubMed ID: 2384299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of bioavailability on the basis of tachycardia after intravenous and oral administration of fenoterol, orciprenaline and salbutamol in non-anaesthetized rats.
    Muacevic G
    Arzneimittelforschung; 1985; 35(1A):406-8. PubMed ID: 2859035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug modulation of superoxide anion production from human neutrophils.
    Fantozzi R; Brunelleschi S; Cremonesi P; Pagella PG; Ciani D; Sportoletti GC
    Int J Tissue React; 1985; 7(2):149-52. PubMed ID: 2863232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The duration of protection from exercise-induced asthma by inhaled salbutamol, and a comparison with inhaled reproterol.
    Higgs CM; Laszlo G
    Br J Dis Chest; 1983 Jul; 77(3):262-9. PubMed ID: 6351889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of reproterol upon tracheo- bronchial, cardiac and cerebral adenylcyclase.
    Marmo E; DiMezza F; Giordano L; Scognamiglio M; Pentimalli D; Marfella A
    Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):389-95. PubMed ID: 6123142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol.
    Hochhaus G; Möllmann H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):342-62. PubMed ID: 1358833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotides regulate the morphologic alterations required for chemotaxis in monocytes.
    Stephens CG; Snyderman R
    J Immunol; 1982 Mar; 128(3):1192-7. PubMed ID: 6120193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors, adenylate cyclase, depression, and lithium.
    Belmaker RH
    Biol Psychiatry; 1981 Apr; 16(4):333-50. PubMed ID: 6261845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of menstrual uterine motility with four beta-adrenergic drugs (author's transl)].
    Cifuentes R; Cobo E
    Reproduccion; 1981; 5(1):31-41. PubMed ID: 6113999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes.
    Linden M
    Br J Pharmacol; 1992 Sep; 107(1):156-60. PubMed ID: 1358381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-2-adrenoceptor agonists up-regulate the in vitro Fc epsilon receptor II/CD23 expression on, and release from, the promonocytic cell line U937 and human blood monocytes.
    Mencia-Huerta JM; Paul-Eugène N; Dugas B; Petit-Frère C; Gordon J; Lagente V; Cairns J; Braquet P
    Int Arch Allergy Appl Immunol; 1991; 94(1-4):91-2. PubMed ID: 1682274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-2-agonists of third generation.
    Palma-Carlos AG; Palma-Carlos GS
    Allerg Immunol (Paris); 1986 Apr; 18(4):31-2, 35. PubMed ID: 2899434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of oral salbutamol with reproterol in reversible airway obstruction.
    Dubey GR; Dabholkar SV; Kamat SR; Mahashur AA; Shah SP; Sonaje AG; Athawale SS
    J Assoc Physicians India; 1986 Mar; 34(3):179-82. PubMed ID: 3525508
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of cyclic AMP in rat uterine inhibitory response to salbutamol during the natural oestrous cycle.
    Ohia SE; Boyle FC
    Arch Int Pharmacodyn Ther; 1988; 293():245-56. PubMed ID: 2844129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of salbutamol, fenoterol, and placebo aerosols on airway resistance in asthmatics.
    Siddorn JA
    Med J Zambia; 1976 Dec-1977 Jan; 10(6):153-6. PubMed ID: 14454
    [No Abstract]   [Full Text] [Related]  

  • 18. Cumulative dose-response curves for comparison of oral bronchodilating drugs. A study of salbutamol and fenoterol.
    Larsson S; Svedmyr N
    Ann Allergy; 1977 Nov; 39(5):362-6. PubMed ID: 921004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer].
    Budmiger H; Kyd K; Scherrer M
    Schweiz Med Wochenschr; 1978 Aug; 108(31):1190-7. PubMed ID: 675213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal control of porcine adipose tissue fatty acid release and cyclic AMP concentration.
    Hu CY; Novakofski J; Mersmann HJ
    J Anim Sci; 1987 Apr; 64(4):1031-7. PubMed ID: 2883168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.